GlassScriptPhysician profile
John G Lane
NPI 1669583191
$300,799.76
in general payments reported to CMS, 2019-2025
22 companies · $71K in 2025
The $71K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,345 · 2020: $189K · 2021: $7,821 · 2022: $25K · 2023: $313 · 2024: $380 · 2025: $71K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $65K · Travel and Lodging: $3,623 · Food and Beverage: $2,944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $65,004.19 |
| Travel and Lodging | $3,622.87 |
| Food and Beverage | $2,943.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $206,604.47 | 2020-2025 | Hyalofast |
| Moximed, INC | $70,498.51 | 2025 | Misha Knee System, Small, Left |
| Vericel Corporation | $18,046.76 | 2019-2023 | Maci |
| Sportstek Medical, INC | $1,916.00 | 2019 | |
| Impactortho, INC. | $1,200.00 | 2021 | |
| Stryker Corporation | $588.26 | 2019-2025 | Triathlon, Blueprint Patient Specific Instrumentation, Mako |
| Zimmer Biomet Holdings, INC. | $311.14 | 2019 | |
| Smith+Nephew, INC. | $307.04 | 2019-2025 | Aetos Shoulder System, Bone Anchors With Arthroscopic Delivery System, Panta 2 |
| Depuy Synthes Sales INC. | $218.71 | 2024-2025 | Orthovisc |
| Medtronic, INC. | $171.05 | 2021 | |
| Abbott Laboratories | $164.90 | 2019-2020 | |
| Cartiheal (2009) LTD. | $146.15 | 2023 | Agili-C |
| Medtronic Vascular, INC. | $132.83 | 2019 | |
| Arthrex, INC. | $130.65 | 2019 | |
| Elevate Surgical Co | $75.56 | 2022-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $71.98 | 2019 | |
| Inari Medical, INC. | $69.08 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $65.07 | 2022 | |
| Bioventus LLC | $50.06 | 2019 | |
| Abbvie INC. | $18.28 | 2024 | |
| Linvatec Corporation | $13.26 | 2023 | Biobrace 23mm |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$559,411.08 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.